Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 118 participants.
Also called NCT03821623
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 118 participants
- Sponsor
- Douglas Seals
- Registry
-
NCT03821623
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03821623. Randomized; triple masking; primary purpose treatment. Start 2019-05-10 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- Condition
- Hypertension
- Condition
- Aging
- Intervention (Drug)
- Nicotinamide riboside
- Intervention (Other)
- Placebo
- Lead sponsor
- Douglas Seals
Record details
- Record id
cardio:ct-nct03821623- Content hash
b0fee8bdfd008d830eae5a094d1189de2d185baeebc5c682dfcf26d92ef6d627